Posted on 10/19/2002 5:25:28 AM PDT by krodriguesdc
Business: Pfizer accused of marketing epilepsy drug illegallyThe Associated Press
BOSTON (October 18, 2002 6:50 p.m. EDT) - Attorneys general in 47 states are investigating whether pharmaceutical giant Pfizer illegally marketed the epilepsy drug Neurontin to physicians.
Washington state Assistant Attorney General David Waterbury said in an affidavit filed in U.S. District Court in Boston this week that he is leading the fraud investigation for the states and the District of Columbia.
Waterbury's statements were attached to a court filing in the civil lawsuit of Dr. David Franklin, a former company sales representative turned whistleblower who has sued both Pfizer and Parke-Davis in Massachusetts. The companies merged two years ago.
In the filing, Waterbury indicated that he requested extensive data from state Medicaid programs over the past eight months, including the prescribing practices of individual doctors for dates before and after their exposure to specific marketing practices.
The affidavit was included with a request from Franklin's attorney, Thomas Greene, seeking more time to gather evidence.
The civil lawsuit and the separate criminal investigation seek to prove that Parke-Davis and its parent company, Warner-Lambert, illegally influenced and paid kickbacks to doctors to prescribe Neurontin for conditions for which the drug was not approved.
A Pfizer spokesman declined to comment on the investigation, but the company has denied the allegations in the past.
Any practitioner will tell you that Neurontin is a highly effective drug for many off-label purposes. However, since the drug is near patent expiration and the costs of trials are extremely high, it is assuredly unprofitable to try to prove its efficacy in traditional manners.
Many drugs have been marketed off label with no complaints. I think what the attorneys general would really like is some money to line their products, not drug reform.
You are exactly right. If the cost of trials were reduced and new applications of the drug allowed for extension of patents, the situation would change.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.